Symptoms of Monkeypox can take 5 to 21 days to appear, so it's important to be aware of the signs during this time and remain in isolation as it is contagious.
A groundbreaking new tool, The Glaucoma Field Defect Classifier (GFDC), developed by eye specialists at Addenbrooke’s Hospital, could transform glaucoma diagnosis and help change the way its managed worldwide.
Open Access Government discusses the prevalence of neglected tropical diseases, including barriers to awareness and the need to scale up effective interventions.
Despite affecting a significant portion of the population, the impact of rheumatic and musculoskeletal diseases (RMDs) is often underestimated, with many people living with RMDs, and their families, in need of greater care and support. Lynne Woolley at Versus Arthritis spoke to Lorna Rothery about the physical and psychological challenges of RMDs and what can be done.
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
Cardiovascular disease (CVD) is the leading cause of death in women worldwide, highlighting the need for greater awareness and research into sex and gender differences impacting cardiovascular care.
Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Researchers at Queen Mary University of London have made a significant breakthrough in the early prediction of dementia, developing a new method that can predict the disease with over 80% accuracy up to nine years before a clinical diagnosis.
